Xiaoli Zhang

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Venues

Cancers

Cells

Vaccines

The Ohio State University

Iowa State University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The Ohio State University Jul 01 2006

United States

Assistant Professor :: Department of Biomedical Informatics

Education History

Iowa State University

United States

PHD :: Molecular Cellular and Develomental Biology

Publications

Walter Hanel, Polina Shindiapina, David A Bond, Yazeed Sawalha, Narendranath Epperla, Timothy J Voorhees, Rina Li Welkie, Ying Huang, Gregory K Behbehani, Xiaoli Zhang, Eric McLaughlin, Wing K Chan, Jonathan E Brammer, Samantha Jaglowski, John C Reneau, Beth A Christian, Basem M William, Jonathon B Cohen, Robert A Baiocchi, Kami Maddocks, Kristie A Blum, Lapo Alinari
A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma. Cancers 15 (5) (2023)
Xian Liu, Yan Chang, Sangyong Choi, Chuanxi Cai, Xiaoli Zhang, Zui Pan
Blocking Store-Operated Ca 2+ Entry to Protect HL-1 Cardiomyocytes from Epirubicin-Induced Cardiotoxicity. Cells 12 (5) (2023)
Elshafa Hassan Ahmed, Mark Lustberg, Claire Hale, Shelby Sloan, Charlene Mao, Xiaoli Zhang, Hatice Gulcin Ozer, Sarah Schlotter, Porsha L Smith, Frankie Jeney, Wing Keung Chan, Bonnie K Harrington, Christoph Weigel, Eric Brooks, Haley L Klimaszewski, Christopher C Oakes, Tamrat Abebe, Muntaser E Ibrahim, Lapo Alinari, Gregory K Behbehani, Polina Shindiapina, Michael A Caligiuri, Robert A Baiocchi
Follicular Helper and Regulatory T Cells Drive the Development of Spontaneous Epstein-Barr Virus Lymphoproliferative Disorder. Cancers 15 (11) (2023)
Xian Liu, Yan Chang, Sangyong Choi, Chuanxi Cai, Xiaoli Zhang, Zui Pan
Blocking Store-Operated Ca 2+ Entry to Protect HL-1 Cardiomyocytes from Epirubicin-Induced Cardiotoxicity. Cells 12 (5) (2023)
Xian Liu, Yan Chang, Sangyong Choi, Chuanxi Cai, Xiaoli Zhang, Zui Pan
Blocking Store-Operated Ca 2+ Entry to Protect HL-1 Cardiomyocytes from Epirubicin-Induced Cardiotoxicity. Cells 12 (5) (2023)
Walter Hanel, Polina Shindiapina, David A Bond, Yazeed Sawalha, Narendranath Epperla, Timothy J Voorhees, Rina Li Welkie, Ying Huang, Gregory K Behbehani, Xiaoli Zhang, Eric McLaughlin, Wing K Chan, Jonathan E Brammer, Samantha Jaglowski, John C Reneau, Beth A Christian, Basem M William, Jonathon B Cohen, Robert A Baiocchi, Kami Maddocks, Kristie A Blum, Lapo Alinari
A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma. Cancers 15 (5) (2023)
Ananya Banerjee, Shurui Cai, Guozhen Xie, Na Li, Xuetao Bai, Kousalya Lavudi, Kevin Wang, Xiaoli Zhang, Junran Zhang, Srinivas Patnaik, Floor J Backes, Chad Bennett, Hongbing Wang
A Novel Estrogen Receptor β Agonist Diminishes Ovarian Cancer Stem Cells via Suppressing the Epithelial-to-Mesenchymal Transition. Cancers 14 (9) (2022)
Elshafa Hassan Ahmed, Eric Brooks, Shelby Sloan, Sarah Schlotter, Frankie Jeney, Claire Hale, Charlene Mao, Xiaoli Zhang, Eric McLaughlin, Polina Shindiapina, Salma Shire, Manjusri Das, Alexander Prouty, Gerard Lozanski, Admasu T Mamuye, Tamrat Abebe, Lapo Alinari, Michael A Caligiuri, Robert A Baiocchi
Targeted Delivery of BZLF1 to DEC205 Drives EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease. Vaccines 9 (6) (2021)
Xiaoli Zhang, Kimerly Powell, Lang Li
Breast Cancer Stem Cells: Biomarkers, Identification and Isolation Methods, Regulating Mechanisms, Cellular Origin, and Beyond. Cancers 12 (12) (2020)
Xiaoli Zhang, Shuai Shao, Lang Li
Characterization of Class-3 Semaphorin Receptors, Neuropilins and Plexins, as Therapeutic Targets in a Pan-Cancer Study. Cancers 12 (7) (2020)

Xiaoli Zhang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xiaoli Zhang